More than 80% of newly-diagnosed diabetic patients in India have at least one cholesterol abnormality.
That is one of the findings of the India Diabetes Study, which revealed that more than 55% of newly-diagnosed type 2 diabetes mellitus (T2DM) patients in India have low HDL-C (high density lipid – cholesterol) values, indicating that they are at higher risk of developing some form of cardiovascular disease in their lifetime. The study also suggested that 42% of all T2DM patients are at a high risk of hypertension.
The nationwide study, supported by Eris Lifesciences and co-authored by 16 doctors between 2020 and 2021, was conducted in partnership with more than 1,900 physicians and had a sample size of 5,080 patients with mean age of 48 years, from across 27 states in India. It has been published in the Public Library of Science journal.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze